Individualized pazopanib dosing - Response

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Access to Document

@article{b1775a43dbdf4a9eaddf87f628f2e696,

title = "Individualized pazopanib dosing - Response",

author = "Verheijen, {Remy B.} and Huitema, {Alwin D R} and Neeltje Steeghs",

year = "2016",

month = dec,

day = "15",

doi = "10.1158/1078-0432.CCR-16-2297",

language = "English",

volume = "22",

pages = "6299",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "24",

}

TY - JOUR

T1 - Individualized pazopanib dosing - Response

AU - Verheijen, Remy B.

AU - Huitema, Alwin D R

AU - Steeghs, Neeltje

PY - 2016/12/15

Y1 - 2016/12/15

UR - http://www.scopus.com/inward/record.url?scp=85007008525&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-16-2297

DO - 10.1158/1078-0432.CCR-16-2297

M3 - Comment/Letter to the editor

C2 - 27980023

AN - SCOPUS:85007008525

SN - 1078-0432

VL - 22

SP - 6299

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 24

ER -